Valsartan - NDSRI's
References
FAQ's
References
- Buehlmayer, Peter; Ostermayer, Franz; Schmidlin, Tibur, Acyl compounds, Ciba-Geigy A.-G., Switzerland, EP443983B1, February 28, 1996
- Daneshtalab, Noriko; Lewanczuk, Richard Z.; Jamali, Fakhreddin, High-performance liquid chromatographic analysis of angiotensin II receptor antagonist valsartan using a liquid extraction method, Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, Volume: 766, Issue: 2, Pages: 345-349, 2002
Frequently Asked Questions
Which analytical methods help analyze Valsartan impurities?
High-performance liquid chromatography (HPLC) and LCMS/ MS are employed to separate and analyze the impurities of Valsartan.
What are the categories of impurities found in Valsartan?
Impurities found in Valsartan can be classified into several categories, which include process-related contaminants, degradation products, residual solvents, and genotoxic impurities.
Do impurities in Valsartan have the potential to evolve?
Valsartan impurities can change over time, influenced by storage conditions, exposure to light, and elevated temperatures.
How should Valsartan impurities be stored in terms of temperature?
The recommendation is to store Valsartan impurities at room temperature, within 2-8 °C.
Note: Products protected by valid patents by a manufacturer are not offered for sale in countries having patent protection. The sale of such products constitutes a patent infringement, and its liability is at the buyer's risk.